Join ISPOR  | Sign up for mailing List  | Follow Us: LinkedIn Twitter Facebook YouTube

October 2005
"ISPOR e-BULLETIN" provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to www.ispor.org.

 Please share these new ISPOR activities with your colleagues

  eBulletin Index

October 200

 Right-click here to download pictures. To help protect your privacy, Outlook prevented automatic download of this picture from the Internet.

 NEW THIS MONTH

**NEW**  ISPOR Press Release Program
**NEW**  Value in Health Vol. 8 No. 5 (September/October 2005)
**NEW** Value in Health "On-Line Early" Manuscripts, Volume 8, Issue 6
**NEW** ISPOR Eighth Annual European Congress – UPDATES (OVER 700 CONTRIBUTED PRESENTATIONS!)
**NEW** ISPOR 2nd Asia-Pacific Congress-UPDATES (MORE THAN 230 ABSTRACTS SUBMITTED)
**NEW** ISPOR Special Interest Group (SIG) – UPDATES
**NEW** ISPOR Asia Consortium–UPDATES
**NEW** 18 New Positions At The ISPOR Website

 ISPOR ONGOING ACTIVITIES 

1.       Publications

2.       Meetings and Congresses

3.       Educational Activities

4.       Student News

5.       ISPOR Special Interest Groups

6.       Committee and Task Force Activities

7.       Hot Topics

8.       Important Dates to Remember

9.       Asia Consortium and Local Chapter News

10.    Employment in Pharmacoeconomics and Outcomes Research

11.    Membership

 


  1. PUBLICATIONS

Top

 

VALUE IN HEALTH  

**NEW** Value in Health: Volume 8, Issue 5, September/October 2005 is online and available this month at: http://www.ispor.org/valueinhealth_index.asp.  The following is the TABLE OF CONTENTS for Value in Health Volume 8, Issue 5, September/October 2005: 

EDITORIALS

Taking Clinical Trials to Task

Michael Drummond 

Random Reflections on the ISPOR CEA Task Force Report On Good Research Practices for Cost-Effectiveness Analysis Alongside Trials

Martin E Backhouse 

TASK FORCE REPORT

Good Research Practices for Cost-Effectiveness Analysis alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report

Scott Ramsey, Richard Willke, Andrew Briggs, Ruth Brown, Martin Buxton, Anita Chawla, John Cook, Henry Glick, Bengt Liljas, Diana Petitti, Shelby Reed  

POLICY AND APPLICATION

Health-Related Quality Of Life and Other Patient-Reported Outcomes in the European Centralised Drug Regulatory Process: A Review of Guidance Documents and Performed Authorizations of Medicinal Products 1995 To 2003

Ágota Szende, MSc, PhD; Nancy Kline Leidy, PhD; Dennis Revicki, PhD  

EMPIRICAL

Health and Economic Consequences of Sevelamer Use for Hyperphosphatemia in Patients on Hemodialysis

Krista F. Huybrechts MS, J. Jaime Caro, MDCM, David A. Wilson, MA, and Judith A. O’Brien, RN 
 

Obesity, Survival, and Hospital Costs–Findings from a Screening Project in Sweden

Sixten Borg, Ulf Persson, Knut Odegaard, Goran Bergland, Jan-Ake Nilsson, and Peter M. Nilsson 
 

Cost-Effectiveness of Anti-Platelet Agents in Secondary Stroke Prevention: The Limits of Certainty

David B. Matchar MD, Gregory P. Samsa PhD, Suping Liu MS 

METHODOLOGY

The Routine Collation of Health Outcomes Data from Hospital Treated Subjects in The Health Outcomes Data Repository (Hodar): Descriptive Analysis From The First 20,000 Subjects

Craig J Currie PhD, Phil McEwan PhD, John R. Peters MD, Tunia C. Patel MSc, and Simon Dixon MSc
 

Functional Assessment in Migraine (FAIM) Questionnaire: Development of an Instrument Based Upon the WHO’s International Classification of Functioning, Disability, and Health

Dev S. Pathak, DBA, Deena J. Chisolm, PhD, and Kathleen A. Weiss, DrPH, PhD, MSN, ENP
 

Patterns and Effectivness of Lipid-Lowering Therapies in a Managed Care Environment

Jay W. Meyer, PhD, Jennifer S. Schultz, John C. O’Donnell, Pankaj A. Patel, and Rahul M. Sasane 

CORRESPONDENCE

Authors’ Response to Comments Regarding Risperidone versus Olanzapine Markov Model Montserrat Vera-Llonch, MD, MPH, Thomas E Delea, MSIA, Erin Richardson, BS, Marcia Rupnow, PhD, Amy Grogg, PharmD, Gerry Oster, PhD. 

VALUE IN HEALTH "ON-LINE EARLY" MANUSCRIPTS

Volume 8, Issue 6, November/December 2005 "On-Line Early" will go on-line later this month. To view these "On-Line Early" articles, simply go to http://www.ispor.org/valueinhealth_index.asp, log on using your membership information, and follow the link. 

ISPOR CONNECTIONS   

ISPOR CONNECTIONS: Volume 11, Issue 4, July/August 2005 is now available to the public at: http://www.ispor.org/news/index_new.asp.   

HEALTH CARE COST, QUALITY, AND OUTCOMES: ISPOR BOOK OF TERMS   

"RTI Health Solutions clients appreciated receiving the ISPOR Book of Terms. They found it to be a valuable resource." Graham Dyck, Director, Marketing and Business Development, RTI Health Solutions, Research Triangle Park, NC, USA. 

This ISPOR publication includes more than 100 detailed monographs covering over 400 terms used in health care delivery, management, and regulation, as well as health care outcomes research including clinical, economic, and quality-of-life research terms. ISPOR member discounted price is $36.00; a 40% discount!  Student/Library/Academic discounted price: $33.00 (a 45% discount). On-line ordering is now available at: http://www.ispor.org/publications/lexicon_index.asp. Contact Stephen Priori at spriori@ispor.org for information on orders over 100.   


  1. ISPOR MEETINGS AND CONGRESSES

Top   

ISPOR EIGHTH ANNUAL EUROPEAN CONGRESS –OVER 850 ABSTRACTS SUBMITTED FOR THE ISPOR EIGHTH ANNUAL EUROPEAN CONGRESS - UPDATES

      6-8 November 2005 Palazzo Degli Affari, Florence , Italy

     "INCORPORATING VALUES INTO HEALTH CARE DECISIONS" 

For more information on the ISPOR 8th Annual European Congress visit:

http://www.ispor.org/congresses/italy1105/index.asp

Posters & Podiums - NEW ISPOR RECORD

Over 700 contributed presentations (64 podium presentations in 4 sessions and over 600 posters in 3 sessions)!  This is the highest number of abstract submissions and presentations in ISPOR's 10-year history. 

Poster Session I: http://www.ispor.org/congresses/italy1105/posters1.asp

Poster Session II: http://www.ispor.org/congresses/italy1105/posters2.asp

Poster Session III: http://www.ispor.org/congresses/italy1105/posters3.asp  

For poster and podium presentation information, visit: http://www.ispor.org/congresses/italy1105/presenters_index.asp  

ISPOR Contributed Issue Panels:

Nine contributed Issue Panels on the following topics: 

*Economic Outcomes Issues

*Clinical Outcomes Issues

*Quality of Life / Patient Reported Outcomes Issues

*Health Policy – Health Care Reimbursement Issues

*Risk Management Issues 

ISPOR Contributed Workshops:

Thirty-two workshops on the following topics:      

*Medication Compliance & Persistence

*Risk Management

*Population Health

*Managed Care Formulary Dossier Development or Research Agendas

*Patient Registries

*Health Technology Assessment 

SYMPOSIUM: Transferring Health Economic Methods and Results from One Country to Another: Issues and Possible Solutions sponsored by: IMS HealthMonday, 7 November 2005, 12:00-13:00

Palazzo degli Affari, Florence Italy (During the ISPOR 8th Annual European Congress)

Issues in transferring health economic methods and results from one country to another as well as potential solutions will be presented and discussed. Specific topics like differences in medical practice, differences in cost structures, difference in data availability will be covered. Moderator: Lieven Annemans, PhD, MSc, MMan, Principal Health Economics and Outcomes Research, Brussels, Belgium; Speakers: Jens Grüger, PhD, Global Head, Pricing & Health Economics, Novartis Pharma AG, Basel, Switzerland; and Frank-Ulrich Fricke, PhD, MSc, Principal Health Economics and Outcomes Research, Fricke & Pirk GmbH – A unit of IMS, Nürnberg, Germany.

SPECIAL EVENT: 

You Are Invited To Attend The

ISPOR 10th Anniversary Party 
Vincigliata Castle
Feisole, Italy

(TO BE HELD DURING THE ISPOR 8TH EUROPEAN CONGRESS)

MONDAY, 7 NOVEMBER 2005
20:00-23:30

WINE TASTING    DINNER BUFFET    MUSIC & DANCING

COMPLIMENTARY TRANSPORTATION

Buses will depart the Palazzo Delgi Affari at 20:15 and depart the Castle at 23:30. To register, go to: http://www.ispor.org/congresses/italy1105/10annivparty.asp

Exhibitor Opportunities: *** SOLD OUT *** 

      Sponsorship Opportunities available at:

https://www.ispor.org/Exhibit_Sponsor/SponsorshipOpportunities.aspx?event=3  

For more details about the Congress, go to: http://www.ispor.org/congresses/italy1105/index.asp 

********************************************************************************

ISPOR 2nd ASIA-PACIFIC CONFERENCE – MORE THAN 230 ABSTRACTS SUBMITTED (100% INCREASE FROM 1ST CONFERENCE)

Shanghai Worldfield Convention Hotel, Shanghai, China • 5-7 March 2006

IMPROVING EVIDENCE AND OUTCOMES IN HEALTH CARE DECISION MAKING IN ASIA PACIFIC: CHALLENGE TO A NEW ERA 

**NEW** More than 230 abstracts submitted to the ISPOR 2nd Asia-Pacific Conference.

CO-ORGANIZED BY

ISPOR Asia Consortium

Fudan University, P.R. China 

CO-SPONSORED BY:

  • Shanghai Municipal Government, P.R. China

  • Ministry of Labor and Social Security, P.R. China

  • Ministry of Health, P.R. China

  • State Food and Drug Administration, P.R. China

  • Shanghai City Food and Drug Administration, P.R. China

  • Peking University, P.R. China

  • The Chinese University of Hong Kong, P.R. China

  • Shanghai Academy of Social Sciences, P.R. China

  • Chinese Medical Association, P.R. China

  • Chinese Health Economics Association, P.R. China

  • Chinese Medical Doctor Association, P.R. China

  • China Licensed Pharmacist Association, P.R. China

  • Chinese Pharmaceutical Association, P.R. China

  • The Pharmaceutical Association of Thailand under the Royal Patronage, Thailand

  • China Social Insurance Association Medical Insurance Branch, P.R. China

  • Chinese Clinical Epidemiology Society, P.R. China

  • Chinese Cochrane Center, P.R. China

For updates, please visit: http://www.ispor.org/conferences/shanghai0306/sponsors.asp 

SHORT COURSES:

  • Introduction to Pharmacoeconomics

  • Introduction to Quality of Life Assessment

  • Meta-Analysis and Systematic Literature Review

  • Introduction to Biostatistics in Clinical Trials

  • Introduction to Decision Analysis

  • Formulary Development

  • Budget Impact Analysis

  • Cost Analysis in Health Care

  • Retrospective Data Analysis

  • Modeling: Structure and Design of a Model

For further information, please visit: http://www.ispor.org/conferences/shanghai0306/p030505.asp 

1st Plenary Session:

Pharmacoeconomics and Outcomes Research Development and Use in Asia

Moderator/Speaker:

Tony YH Tarn PhD, Director, Department of Pharmacy, Taipei City  

Hospital, Taipei, Taiwan

Speakers: Shanlian Hu, MD, MSc, Professor, School of Public Health, Fudan University, Shanghai, China; Isao Kamae, MD, PH, Professor, Graduate School of Medicine, Kobe University, Kobe, Japan, Syed Mohamed Aljunid, MD, MSc, PhD, FAMM, Professor of Health Economics and Head of Department of Community Health, and Faculty of Medicine, Universiti Kebangsaan Malaysia; Shu-Chen Li, PhD, MS, MBA, Assistant Professor, Department of Pharmacy, National University of Singapore, Singapore, Bong-Min Yang, PhD, Professor of Economics and Dean, School of Public Health, Seoul National University, South Korea; and Viroj Tangcharoensathien, PhD, Director of International Health Policy Program Ministry of Public Health, Thailand. 

2nd Plenary Session:

Development and Implementation of Pharmacoeconomics Requirements: International Experiences

Moderator/Speaker: Wen Chen, PhD, Professor and Associate Dean, School of Public Health, Fudan University

Speaker: Michael Drummond, PhD, Director, Centre of Health Economics, University of York, Heslington, York, UK

Speaker: Suzanne Hill, PhD, Associate Professor, Clinical Pharmacology
Faculty of Health University of Newcastle, Australia

10 PODIUM SESSIONS, 4 WORKSHOP SESSIONS and 9 CO-SPONSORED SPECIALSESSIONS:

For details, go to: http://www.ispor.org/conferences/shanghai0306/p030605.asp; http://www.ispor.org/conferences/shanghai0306/p030705.asp 

FINANCIAL SUPPORT OPPORTUNITIES

Financial support opportunities are available at: https://www.ispor.org/Exhibit_Sponsor/SponsorshipOpportunities.aspx?event=1           

EXHIBITOR OPPORTUNITIES:

Exhibitor opportunities are available at: https://www.ispor.org/Exhibit_Sponsor/ExhibitorOpportunities.aspx?event=1 

EARLY REGISTRATION DEADLINE: 5 FEBRUARY 2006

For further conference information, go to: http://www.ispor.org/conferences/shanghai0306/index.asp 


  1. EDUCATION ACTIVITIES

Top           

ISPOR SHORT COURSES–ISPOR 8TH ANNUAL EUROPEAN CONGRESS 

Saturday, 6 November Short Courses: 

Pharmacoeconomics for the Health Care Decision-Maker

Faculty: Lorne Basskin PharmD, Clinical Coordinator, North Shore Medical Center, Cooper City, FL, USA.

The Analysis and Interpretation of Quality of Life and Patient Reported Outcomes

Faculty: Linda Abetz MA, Director, Questionnaire Development and Validation, Mapi Values, Bollington, UK; Christine de la Loge Director, Psychometrics and Statistics Mapi Values, Lyon, France. 

European Databases and Retrospective Database Analysis

Faculty: Bernd Brϋggenjϋrgen MD, MPH, Coordinator-Health Economics, University of Berlin, Berlin, Germany.

 

Cost Estimation and Assessing Financial (Budget) Impact of New Health Care Technologies  

Faculty: Josephine Mauskopf PhD, Global Head, Health Economics and Outcomes Strategy, RTI Health Solutions, Research Triangle Park, NC, USA; C. Daniel Mullins PhD, Professor and Chair of Pharmaceutical Health Services Research, University of Maryland, School of Pharmacy, Baltimore, MD, USA.

 

Pharmacoeconomic Modeling
Faculty
: Uwe Siebert MD, MPH, MSc
, Decision Scientist, Director of the Cardiovascular Research Program, Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA and Director of the Program on Health Technology Assessment and Decision Sciences (HTA&DS), Institute for Medical Informatics, Biostatistics, and Epidemiology, University of Munich, Munich, Germany; Gaby Sroczynski MPH, Decision Scientist, Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA and Bavarian Public Health Research and Coordinating Center, University Munich, Germany.

 

For Saturday Short Courses descriptions, go to: http://www.ispor.org/congresses/italy1105/satsc.asp

 

Sunday, 6 November Short Courses: 

Elements of Pharmaceutical Pricing

Faculty: Jack Mycka, President, Optimar Strategic Consulting LLC, Montclair, NJ, USA; Renato Dellamano PhD, President, ValueVector (Value Added Business Strategies), Milan, Italy

 

Transferability of Cost-Effectiveness Data between Countries

Faculty: Michael Drummond PhD, Director, University of York, Centre for Health Economics, York, UK

 

Health Care and Reimbursement Systems in Europe 

Faculty: Gordon Carey Cambridge Pharma Consultancy Ltd., Cambridge, UK 

Bayesian Methods in Economic Evaluations

Faculty: Anthony O'Hagan PhD, Professor of Statistics, University of Sheffield, Sheffield, South Yorkshire, UK; Jeremy E. Oakley PhD, Lecturer, Department of Probability and Statistics, University of Sheffield, Sheffield, UK; John Williams Stevens BSc, Statistician, AstraZeneca, Leicestershire, UK

 

Discrete Event Simulation for Economic Analysis

Faculty: J. Jaime Caro MDCM, FCRPC, FACP, Adjunct Professor of Medicine, Adjunct Professor of Epidemiology and Biostatistics, McGill University, Montreal PQ and Scientific Director, Caro Research Institute, Concord, MA, USA; Jörgen Möller MSc Mech Eng, Simulation Specialist, Caro Research Institute, Concord, MA, USA

 

Utility Measurements (Preference-Based Techniques)

Faculty: Jan Busschbach PhD, Senior Investigator, Department for Medical Psychology and Psychotherapy and Erasmus Medical Center, Rotterdam, The Netherlands; Elly Stolk MSc, Institute for Medical Technology Assessment (iMTA), Erasmus University Medical Center Rotterdam, The Netherlands.

 

For Sunday Short Courses descriptions, go to: http://www.ispor.org/congresses/italy1105/sunsc.asp

 

************************** 

ISPOR SHORT COURSES–ISPOR 11TH ANNUAL INTERNATIONAL MEETING – May 2006 

Saturday, May 20, 2006 

Pharmacoeconomics for Decision-makers

Faculty: Lorne Basskin PharmD, Clinical Coordinator, Pharmacy Services, North Shore Medical Center, Miami, FL, USA and President, Trinka Publications, Cooper City, FL, USA 

Retrospective Database Analysis – Econometric Methods

Faculty: William H. Crown PhD, i3 Magnifi, Auburndale, MA, USA 

Modeling: Design and Structure of a Model

Faculty: Marc Botteman MA, Managing Partner, PharMerit North America, Bethesda, MD , USA 

Finding and Extracting Cost Data

Faculty: Judith A. O'Brien RN, BSPA, Vice President, Director of Cost Development Research, Caro Research Institute, Concord, MA, USA 

Bayesian Analysis: Overview

Faculty: Bryan Luce MBA, PhD, Founder and Senior Research Leader, The MEDTAP Institute at United BioSource Corporation, Bethesda, MD, USA  

Financial Impact / Cost of Illness

Faculty: Josephine Mauskopf PhD, Global Head, Health Economics and Outcomes Strategy, RTI Health Solutions, Research Triangle Park, NC, USA; C. Daniel Mullins PhD, Professor and Chair of Pharmaceutical Health Services Research, University of Maryland, School of Pharmacy, Baltimore, MD, USA

 Bayesian Analysis: Applications

Faculty: Bryan Luce MBA, PhD, Founder and Senior Research Leader, The MEDTAP Institute at United BioSource Corporation, Bethesda, MD, USA  

Qualitative Methods for Quality of Life/Patient-reported Outcomes

Faculty: Judith Barr, Associate Professor and Director, Northeastern University, Boston, MA, USA
 

Sunday, May 21, 2006

 

Cost-Effectiveness Analysis alongside Clinical Trials

Faculty: TBD 

Use of Real World Data in Outcomes Research

Faculty: TBD 

Bayesian Analysis: Advanced

Faculty: Bryan Luce MBA, PhD, Founder and Senior Research Leader, The MEDTAP Institute at United BioSource Corporation, Bethesda, MD, USA  

Discrete Event Simulation for Economic Analyses

Faculty: J.Jaime Caro MDCM, FCRPC, FACP, Adjunct Professor of Medicine, Adjunct Professor of Epidemiology and Biostatistics, McGill University, Montreal PQ and Scientific Director, Caro Research Institute, Concord, MA, USA; Jörgen Möller MSc Mech Eng, Simulation Specialist, Caro Research Institute, Concord, MA, USA 

Advanced Quantitative Methods for Quality of Life / Patient-Reported Outcomes

Faculty: John Ware PhD, CEO & Chief Science Officer, Quality Metric Incorporated, Lincoln, RI, USA 

Elements of Pharmaceutical/Biotech Pricing I - Introduction

Faculty: Jack Mycka, President, Optimar Strategic Consulting LLC, Montclair, NJ, USA;
Renato Dellamano PhD, President, ValueVector (Value Added Business Strategies), Milan, Italy
 

Statistical Considerations in Economic Evaluations

Faculty: Henry Glick PhD, University of Pennsylvania, School of Medicine, Philadelphia, PA, USA; Jalpa Doshi PhD, University of Pennsylvania, School of Medicine, Philadelphia, PA, USA;
Daniel Polsky PhD, University of Pennsylvania, School of Medicine, Philadelphia, PA, USA  

Propensity Scores and Comorbidity Risk Adjustment

Faculty: Fadia Shaya MPH, PhD, Assistant Professor/Associate Director, University of Maryland School of Pharmacy, Center on Drugs and Public Policy, Baltimore, MD, USA 

Patient Registries: Overview & Application

Faculty: Jeff Trotter MBA, President, Ovation Research Group, Highland Park, IL, USA 

Utility Measures in Health Economics and Outcomes Research

Faculty: F. Reed Johnson PhD, Senior Fellow, RTI Health Solutions, Research Triangle Park, NC, USA 

Outcomes Research for Medical Devices & Diagnostics

Faculty: TBD 

Case Studies in Pharmaceutical/Biotech Pricing II – Advanced

Faculty: Jack Mycka, President, Optimar Strategic Consulting LLC, Montclair, NJ, USA; Renato Dellamano PhD, President, ValueVector (Value Added Business Strategies), Milan, Italy 

Risk Assessment: Analysis and Management

Faculty: TBD 

ISPOR DISTANCE LEARNING PROGRAM MODULES

http://www.ispor.org/distancelearning/index.asp

The following module topics are currently available (over 40 modules):

·      Pharmacoeconomics

·      Pharmacoeconomic Evaluations & Methods

·      Cost-Effectiveness Analysis

·      Cost-Benefit Analysis

·      Cost-Utility Analysis

·      Patient-Reported Outcomes (Utilities, Health-Related Quality Of Life, Treatment  Satisfaction, Treatment Adherence, Patient Preferences)

·      Study Design in Pharmacoeconomics

·      Guidelines and Reference Standards

·      Pharmacoeconomics in Drug Development, Reimbursement and Marketing


  1. STUDENT NEWS

Top 

START AN ISPOR STUDENT CHAPTER! Over 30 student chapters! For more information:

http://www.ispor.org/student/chapters_index.asp 

POST YOUR RESUME ONLINE for employers to view for IPRAP – Internship – Professional Recruitment Center http://www.ispor.org/iprap/index.asp 

For more details on the ISPOR Student Network, please visit: http://www.ispor.org/student/student_index.asp        


  1. ISPOR SPECIAL INTEREST GROUPS (SIG)

Top 

VALUE-BASED REIMBURSEMENT SIG 

For more details on this SIG, please visit: http://www.ispor.org/sigs/reimbursement.asp 

HEALTH TECHNOLOGY ASSESSMENT SIG 

For more details on this SIG, please visit: http://www.ispor.org/sigs/hta.asp

TRANSLATING RESEARCH TO CLINICAL PRACTICE SIG  

For more details on this SIG, please visit: http://www.ispor.org/sigs/cp.asp 

PATIENT REGISTRY SIG 

Patient Registry SIG Forum: Monday, 7 November 2005, 17:00-18:00, at the ISPOR 8th Annual European Congress. Topic: Patient Registries: Opportunity And Responsibility Moderator: Jeffrey Trotter MM, ISPOR Patient Registry SIG Chair & President, Ovation Research Group, Highland Park, IL, USA; Speaker: Leanne Larson MHA, Senior Vice President, Patient Registries, Ovation Research Group, Highland Park, IL, USA. 

QUALITY OF LIFE SIG 

For more details on this SIG, please visit: http://www.ispor.org/sigs/qol.asp

 
MEDICATION COMPLIANCE & PERSISTENCE SIG

Issues & Methods Working Group

Please see: Poster Session III (Tuesday 8th November: ISPOR 8th European Congress) 

PHP46: DEFINING COMPLIANCE/ADHERENCE AND PERSISTENCE: ISPOR SPECIAL INTEREST WORKING GROUP Poster Session III (Tuesday 8th November: ISPOR 8th European Congress)

Burrell A1, Wong P2, Ollendorf D3, Fuldeore M4, Roy A5, Fairchild C6, Cramer J7

1Sanofi-Aventis, Bridgewater, NJ, USA; 2 Good Samaritan Hospital, Dayton, OH, USA; 3 PharMetrics, Inc, Watertown, MA, USA; 4 Walgreens Health Services, Deerfield, IL, USA; 5 West Virginia University, Morgantown, WV, USA; 6 Alcon Laboratories, Fort Worth, TX, USA; 7 Yale University School of Medicine, West Haven, CT, USA 

Economics of Medication Compliance Working Group

Attend the workshop organized by this Working Group at the forthcoming 8th European Congress.

Monday 7 November 2006: 10.45-11.45 am: W10 Incorporating Measure of Compliance & Persistence In Pharmacoeconomic Evaluations. 

Analyses Standards Working Group

Attend the workshop organized by this Working Group at the forthcoming ISPOR 8th European Congress

Sunday 6 November 2006, at 15.30-16.30: W2: Methods for Medication Compliance Studies: Patient Compliance as a Predictor of Clinical and Economic Outcomes. 

For more details on the work of this SIG please visit http://www.ispor.org/sigs/medication.asp and attend the Forum to be held on Monday 7 November 17.00-18.00 at the ISPOR 8th European Congress, Florence, Italy. 
 

RETROSPECTIVE DATABASE SIG 

Classification of Databases Working Group – ISPOR DIGEST OF INTERNATIONAL DATABASES

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is developing an electronic index (Digest) of key attributes of health care databases around the world at the ISPOR website, which will be accessible to the public. This Digest is an initiative of the ISPOR Retrospective Database Special Interest Group. For more information about this ISPOR Special Interest Group, see: http://www.ispor.org/sigs/retrospective_db.asp.
 

RISK MANAGEMENT SIG

The Risk Management Special Interest Group (RMSIG) Working Groups are: 

  • Risk/Benefit Assessment Working Group–Co-Chairs: Larry Liu MD, PhD, Director, Anti-Infectives US Outcomes Research, Pfizer, New York, NY, USA; and Suellen Curkendall PhD, Principal Investigator, Cerner Health Insights, Vienna, VA, USA.
  • Risk/Benefit Interventions Working Group–Chair: Anthony Lockett MBA, MD, PhD, Medical Director OHI, Leeds, W. Yorkshire, UK
  • Risk/Benefit Management Best Practices Working Group–Chair: TBD
  • Risk/Benefit Communication Working Group–Chair: Ateequr Rahman MBA, PhD, Assistant Professor, College of Pharmacy, Shenandoah University, Winchester, Virginia, USA

For an overview of this RMSIG initiative, see the article “ISPOR Risk Management Special Interest Group–A Plan for Action,” in ISPOR CONNECTIONS, September/October 2005 issue. 

For more details on this SIG, please visit: http://www.ispor.org/sigs/rm.asp and join as a reference or leadership group member.

Special Interest Group membership is open to ALL ISPOR members. To JOIN any SIG: http://www.ispor.org/sigs/joinsig.htm


  1. ISPOR BOARD, COMMITTEE, AND TASK FORCE ACTIVITIES

Top       

AWARD COMMITTEE ACTIVITIES 

ISPOR AVEDIS DONABEDIAN OUTCOMES RESEARCH LIFETIME ACHIEVEMENT AWARD 

The ISPOR Awards Committee is seeking nominees for the ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award. 

See http://www.ispor.org/awards/donabedian_.asp

For award description, criteria, selection process, nature of the award, and past recipients. 

The deadline to submit nominees is DECEMBER 15, 2005. 

ISPOR COMMUNICATIONS TASK FORCE 


**NEW**
ISPOR PRESS RELEASE PROGRAM 

The ISPOR Press Release Program has been designed to increase the awareness of health care outcomes research and its usefulness in health care decisions to the general public.

This program offers authors of contributed scientific papers from ISPOR Meetings/Congresses as well as in Value in Health to publicize their scientific findings in much simpler terms to reach a broader public audience. Selected ISPOR Press Releases will also be forwarded to national and international media. All news releases will be published at: http://www.ispor.org/pressrelease/index.asp and the ISPOR Research Digest, a web database of more than 6,000 research presentations. 

To learn more about the ISPOR Press Release Program, go to: http://www.ispor.org/pressrelease/pressreleaseformat.asp 

To view past media releases, go to: http://www.ispor.org/pressrelease/index.asp 

ISPOR TASK FORCE: USING "REAL WORLD" DATA IN COVERAGE AND REIMBURSEMENT DECISIONS

Using ‘Real World’ Data In Coverage And Reimbursement Decisions Task Force Forum: Monday, 7 November 2005, from 17:00-18:00, at the ISPOR 8th Annual European Congress. Moderators: Task Force Co-Chairs: Peter Neumann ScD, Associate Professor of Policy and Decision Sciences, Harvard School of Public Health , Boston, MA, USA, and Lou Garrison PhD, Professor, Department of Pharmacy, University of Washington, Seattle WA, USA; Speakers: Deborah Marshall, PhD, Director, Research & Development Health Economics & Outcomes Research, Innovus Research Inc., ON, Canada; Dan Mullins PhD, Professor and Chair, Pharmaceutical Health Services, Research University of Maryland School of Pharmacy, Baltimore, MD, USA; Pennifer Erickson PhD, Co-founder, O.L.G.A., State College, PA, USA   

ISPOR HEALTH CARE STRATEGY COUNCIL

Health Care Strategy Council Forum: Monday, 7 November 2005, 17:00-18:00, at the ISPOR 8th Annual European Congress. Topic: A Word from Health Care Decision-Makers on Outcomes Research. Moderator: Marcus Wilson PharmD, ISPOR Health Care Strategy Council Chair & President, HealthCore Inc., Wilmington, DE, USA; Speakers: Dennis W Raisch PhD, Department of Veterans Affairs, Clinical Research Pharmacy Coordinating Center, Albuquerque, NM, USA; Brian Sweet B.S. Pharm, MBA, WellPoint Pharmacy Management, West Hills, CA, USA; Laurie Beth Burke RPh, MPH, FDA, CDER, DDMAC, Rockville, MD, USA; Andreas Laupacis MD, MSc, FRCPC, Institute for Clinical Evaluative Sciences, Toronto, Canada; Eugene Eavy RPh, MBA, St. Joseph Mercy Health System, Ann Arbor, MI, USA; James MacKay MD, Providence Health Plan, Beaverton, OR, USA; Joseph Singer MD, Integrated Research Network, HealthCore, Inc., Wilmington, Delaware, USA; Marcus Wilson PharmD, Health Core, Inc, Wilmington,  DE, USA; and Michael Drummond PhD, University of York, Centre for Health Economics, Heslington, York, UK. 

ISPOR TASK FORCE: BUDGET IMPACT ANALYSIS 

The Budget Impact Analysis Task Force was created in May 2005 to establish good research practice methods for conducting and reviewing budget impact analyses.  The report of this Task Force will be published in ISPOR Value in Health and at the ISPOR website in 2006.  

The Task Force is presenting a workshop summary of their report at the upcoming ISPOR 8th Annual European Congress in Florence, Italy, November 2005.  The workshop will take place Monday, November 5 at 5:00 PM and will feature the following speakers:  

Task Force Co-Chairs: Josephine Mauskopf PhD, VP, Health Economics, RTI Health Solutions, RTI International, Research Triangle Park, NC, USA; Sean Sullivan MS, PhD, RPh, Professor and Director, University of Washington, Pharmaceutical Outcomes Research and Policy Program, Seattle, WA, USA 

Lieven Annemans MSc, PhD, Health Economist Ghent University, Senior Consultant Global Health Economics, HEDM and IMS Health, Brussels, Belgium; J. Jaime Caro MD, Scientific Director, Caro Research, Concord, MA, USA; C. Daniel Mullins PhD, Professor and Chair, Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD, USA; Mark Nuijten MBA, MD, PhD, Sr. Research Scientist, Dir. of Business Dev., MEDTAP International, Inc., Jisp, The Netherlands; Ewa Orlewska PhD, Lecturer, Pharmacoeconomics Centre Warsaw, Warsaw; Paul Trueman MA, Sales & Marketing Director, York Health Economics Consortium, University of York, York, UK; John Watkins MPH, RPh, Pharmacy Manager, Formulary Development, Premera Blue Cross, Bothell, WA, USA; Andrew Wilson BMedSc, MB SC, FRACP, MSc, Deputy Director and Professor of Public Health, University of Queensland, School of Public Health, Brisbane, Australia 

For more, please visit the ISPOR website at: http://www.ispor.org/workpaper/practices_index.asp.

  1. HOT TOPICS

Top 

NEW DRUG COVERAGE INCLUDES OPTIONS FOR ADDITIONAL BENEFITS AND SAVING MONEY–COST, COVERAGE AND CONVENIENCE CAN BE FOCUS OF CHOICE

 

September 30, 2005 – All people with Medicare will have a range of choices to enable them to get prescription drug coverage that reflects their preferences, including options with low premiums and options offering more coverage than Medicare’s standard drug benefit, the Centers for Medicare & Medicaid Services (CMS) announced today.

 

For full text of the article, see: http://www.hhs.gov/news/press/2005pres/20050930.html


  1. IMPORTANT DATES TO REMEMBER

Top  

8-11 November 2005 – ISPOR 8th European Congress, Palazzo Degli Affari, Florence, Italy 

9 January 2006 – On-line abstract submission deadline for ISPOR 11th Annual International Meeting, Marriot Philadelphia, Philadelphia , PA, USA 

5 February 2006ISPOR 2nd Asia-Pacific Conference, Shanghai Worldfield Convention Hotel, Shanghai, China **EARLY REGISTRATION DEADLINE**

5-7 March 2006 – ISPOR 2nd Asia-Pacific Conference, Shanghai Worldfield Convention Hotel, Shanghai, China 

20-26 May 2006 – ISPOR 11th Annual International Meeting, Marriott Philadelphia, Philadelphia, PA, USA


  1. ASIA CONSORTIUM AND LOCAL CHAPTER NEWS

Top 

ISPOR ASIA CONSORTIUM

Asia Consortium extends its present to Pakistan. Now its members are form China, India, Japan, Malaysia, Pakistan, Singapore, South Korea, Taiwan and Thailand. For more details on this consortium, please visit: http://www.ispor.org/consortiums/asia.asp 

ISPOR Japan Chapter inaugurated on 1 September, 2005.

For more details on this chapter, please visit: http://www.ispor.org/regional_chapters/Japan/index.asp

 

ISPOR 2ND ASIA-PACIFIC CONFERENCE–MORE THAN 230 ABSTRACTS SUBMITTED (100% INCREASE FROM 1ST CONFERENCE)

The ISPOR 2nd Asia-Pacific Conference will be held in Shanghai, China, 5-7 March 2006. More than 230 abstracts have been received. Early registration deadline is 5 February 2006. 

For more details on the 2nd Asia-Pacific Conference, please visit: http://www.ispor.org/conferences/shanghai0306/index.asp 

For more details on other ISPOR Local Chapters, please visit: http://www.ispor.org/regional_chapters/index.asp

 


  1. EMPLOYMENT

Top

**NEW** 18 NEW POSITIONS AT THE ISPOR WEBSITE: http://www.ispor.org/employment/employment_index.asp 

Advertise your positions on ISPOR Website (~1 million hits per month) 

INTERNSHIPS

Visit ISPOR's Internship-Professional Recruitment Assistance Program (I-PRAP) at http://www.ispor.org/iprap/index.asp  

STUDENTS: Post your CVs/resumes for employers to view and search for internship positions available.  Nine student resumes posted!   

EMPLOYERS: Post your Intern positions for FREE and access CVs/resumes from students.  

If you have any questions, please contact: iprap@ispor.org

ISPOR Professional Recruitment Center at the 8th European Congress 

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) will provide its successful Professional Recruitment Center (PRAP) at the ISPOR 8TH ANNUAL EUROPEAN CONGRESS, 6-8 November 2005, in Florence, Italy.  

 Our recruitment center provides:

**A listing of available positions

**A listing of qualified candidates

**A mailbox system for applicants and employers

**Private interview rooms 

For Employers:

  • This is a targeted, efficient and cost-effective recruiting solution for you to find QUALIFIED candidates to fill positions in Health Economics, Outcomes, Pharmacoeconomics, Health Systems, Medical Affairs, Clinical Research or Marketing departments.  You may post a job opportunity even if your representative will not be present at the conference.
  • The fee for an employer is $1000 US for the first advertised position and $500 for each additional position. This includes a 1/4 page advertisement in the Annual Meeting program distributed to ALL attendees -- a $700 value.
  • Academic Institutions receive a 50% discount for faculty positions posted.

For Candidates:

  • This confidential service is FREE for ISPOR member applicants or registered meeting participant applicants.
  •  Members can register even if you will not be present at the conference.  

For more information, visit our website at http://www.ispor.org/prap.asp 

 


 

  1. ISPOR MEMBERSHIP

Top

Update your email address at https://www.ispor.org/members/addresschange.asp! Your email address is required as part of your log in information in the members only section of the ISPOR website.  


eBulletin Index

 
 

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2014 International Society for Pharmacoeconomics and Outcomes Research. All rights reserved under International and Pan-American Copyright Conventions. 
Website design by Eagle Systems USA, Inc.